Targeting the receptor tyrosine kinase MerTK shows therapeutic value in gastric adenocarcinoma.

MLA

Wirsik, Naita Maren, et al. “Targeting the Receptor Tyrosine Kinase MerTK Shows Therapeutic Value in Gastric Adenocarcinoma.” Cancer Medicine, vol. 13, no. 7, Apr. 2024, pp. 1–14. EBSCOhost, https://doi.org/10.1002/cam4.6866.

APA

Wirsik, N. M., Chen, M., He, L., Yasar, U., Gaukel, J., Quaas, A., Nienhüser, H., Leugner, E., Yuan, S., Schleussner, N., Jung, J., Plücker, J. S., Schneider, M., & Schmidt, T. (2024). Targeting the receptor tyrosine kinase MerTK shows therapeutic value in gastric adenocarcinoma. Cancer Medicine, 13(7), 1–14. https://doi.org/10.1002/cam4.6866

Chicago

Wirsik, Naita Maren, Mingyi Chen, Liping He, Uraz Yasar, Justus Gaukel, Alexander Quaas, Henrik Nienhüser, et al. 2024. “Targeting the Receptor Tyrosine Kinase MerTK Shows Therapeutic Value in Gastric Adenocarcinoma.” Cancer Medicine 13 (7): 1–14. doi:10.1002/cam4.6866.